- Home
- Market News & Reports
- Market News
- News Details
Web Content Viewer
Saudi Exchange Company announces the termination of AlRajhi Capital Market Making Agreement for AlModawat Specialized Medical Co. (9594)
Saudi Exchange Company announces the approval of AlRajhi Capital’s request to terminate the Market Making activities for AlModawat Specialized Medical Co. (9594). effective 07/04/2026.
Back to Market NewsRelated News
-
The Capital Market Authority approves the capital increase request for Purity for Information Technology Company through the issuance of bonus shares
The CMA has issued its resolution approving Purity for Information Technology Company's request to increase its capital from SAR (15,000,000) to SAR (20,000,000) through issuing (1) bonus share for every (3) existing shares owned by the shareholders who are registered in the shareholders registry at the Security Depository Center as of the closing of the second trading day after the due date which will be determined later by the Company's board, such increase will be paid by transferring an amount of SAR (5,000,000) from “Retained earnings” account to the Company's capital. Consequently, increasing the Company's outstanding shares from (15,000,000) shares to (20,000,000) shares, by an increase of (5,000,000) shares. The extraordinary general assembly shall be held within six months from this approval date and the Company shall satisfy all regulatory requirements and applicable laws.
06/04/2026 16:49:02 -
CMA Announces the Approval of Public Offering of Al Rajhi GCC Financial Sector Equity Fund"
The CMA has issued its resolution approving the public offer, by "Al Rajhi Capital”, of “Al Rajhi GCC Financial Sector Equity Fund” An investment decision without reading the Terms and Conditions carefully or fully reviewing its content may involve high risk. Therefore, investors should carefully read the Terms and Conditions which includes detailed information on the Fund, investment strategy and risk factors, and carefully study it to be able to assess the feasibility of taking into consideration the associated risks. If the Terms and conditions proves difficult to understand, it is recommended to refer to the fund manager for more information. The CMA's approval of the fund should never be considered as a recommendation to subscribe in the fund, The CMA's approval of the fund merely means that the legal requirements as per the Capital Market Law and its Implementing Regulations have been met.
06/04/2026 16:46:46 -
Saudi Exchange Company announces the termination of AlRajhi Capital Market Making Agreement for AlModawat Specialized Medical Co. (9594)
Saudi Exchange Company announces the approval of AlRajhi Capital’s request to terminate the Market Making activities for AlModawat Specialized Medical Co. (9594). effective 07/04/2026.
06/04/2026 15:51:23 -
The Saudi Exchange announces that the fluctuation limits for Riyad Bank will be based on a share price of ^21.83
Riyad Bank EGM held on Sunday 2026/04/05 has approved the capital increase via bonus shares. Thus, the fluctuation limits on Monday 2026/04/06 for Riyad Bank will be based on a share price of SAR 21.83 and the outstanding orders will be canceled. Furthermore, the Securities Depository Center (Edaa) will deposit the addition shares into the investor’s portfolios by Wednesday 2026/04/08.
06/04/2026 08:27:35 -
The Capital Market Authority approves the capital increase request for Middle East Pharmaceutical Industries Company through the issuance of bonus shares
The CMA has issued its resolution approving Middle East Pharmaceutical Industries Company's request to increase its capital from SAR (200,000,000) to SAR (350,000,000) through issuing (3) bonus shares for every (4) existing shares owned by the shareholders who are registered in the shareholders registry at the Security Depository Center as of the closing of the second trading day after the due date which will be determined later by the Company's board, such increase will be paid by transferring an amount of SAR (150,000,000) from “Retained earnings” account to the Company's capital. Consequently, increasing the Company's outstanding shares from (20,000,000) shares to (35,000,000) shares, by an increase of (15,000,000) shares. The extraordinary general assembly shall be held within six months from this approval date and the Company shall satisfy all regulatory requirements and applicable laws.
05/04/2026 16:25:32